Cas:885271-74-9 methyl 7-methoxy-3,4-dihydro-2H-chromene-3-carboxylate manufacturer & supplier

Chemical Name:methyl 7-methoxy-3,4-dihydro-2H-chromene-3-carboxylate

CAS.NO:885271-74-9

Synonyms:2H-1-Benzopyran-3-carboxylicacid,3,4-dihydro-7-methoxy-,methyl ester;7-METHOXY-CHROMAN-3-CARBOXYLIC ACID METHYL ESTER;METHYL 7-METHOXYCHROMAN-3-CARBOXYLATE

Molecular Formula:C₁₂H₁₄O₄

Molecular Weight:222.23700

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:44.76000

Exact Mass:222.08900

LogP:1.41930

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2H-1-Benzopyran-3-carboxylicacid,3,4-dihydro-7-methoxy-,methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,METHYL 7-METHOXYCHROMAN-3-CARBOXYLATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,METHYL 7-METHOXYCHROMAN-3-CARBOXYLATE Use and application,2H-1-Benzopyran-3-carboxylicacid,3,4-dihydro-7-methoxy-,methyl ester technical grade,usp/ep/jp grade.

Related News: J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. methyl 7-methoxy-3,4-dihydro-2H-chromene-3-carboxylate manufacturer Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. methyl 7-methoxy-3,4-dihydro-2H-chromene-3-carboxylate supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. methyl 7-methoxy-3,4-dihydro-2H-chromene-3-carboxylate vendor J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. methyl 7-methoxy-3,4-dihydro-2H-chromene-3-carboxylate factory The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.